ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
6
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,058
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Behavioural and cognitive benefits of rivastigmine in nursing home patients with Alzheimer’s disease and related dementias: a 26-week follow-up
Author(s):
R. Hartman
,
R Anand
,
B Etemad
Publication date:
2001
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Tobacco Prevention & Cessation
Data availability:
ScienceOpen disciplines:
Medicine
,
Health & Social care
Comments
Comment on this article
Sign in to comment
Similar content
1,058
Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease.
Authors:
Raffaella Di Cagno
,
Francesco Bove
,
Davide Quaranta
…
A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
Authors:
Simona Gabriella Di Santo
,
Federica Prinelli
,
Fulvio Adorni
…
A ramdomized trial evaluating the efficacy and safety of ENA 713 (Rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer disease for the ENA 713 B352 Study Group
Authors:
J Corey-Bloom
,
R. ANAND
,
J Veach
…
See all similar